NP35923 Cardiovascular & Respiratory Medicines

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

This public procurement record has 2 releases in its history.

Award

25 Jul 2023 at 10:16

Tender

11 Jan 2023 at 11:36

Summary of the contracting process

The procurement process is currently in the Tender stage and is being carried out by the buying organisation named [Buying Organisation]. The title of the contract is [Title], and it falls under the [Industry Category] industry category. The procurement is taking place in [Location], with a deadline set for [Deadline Date]. Businesses well-suited to compete in this tender should consider [Key Details About the Tender].

This tender offers potential growth opportunities for businesses looking to expand their operations in the [Industry Category] sector. Companies with expertise in [Specific Business Areas] would be well-placed to participate and secure this contract. Understanding the needs and requirements of the buying organisation is crucial for successfully competing in this procurement process. Businesses should prepare to present their capabilities and competitive advantages to stand out among other bidders.

How relevant is this notice?

Notice Title

NP35923 Cardiovascular & Respiratory Medicines

Notice Description

This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods were split into eighteen (18) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

Lot Information

Epoprostenol powder and solvent (pH10.5) for solution for infusion vials

Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH10.5) for solution for infusion vials to NHS Scotland. The Authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Epoprostenol powder and solvent (pH12) for solution for infusion vials

Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority has awarded a multi-supplier unranked framework agreement for the Lot to a maximum of 6 Framework Participants.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Epinepherine (Adrenaline) Pre-filled syringes

Supply of Epinephrine (Adrenaline) Pre-filled syringes to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Epinephrine (Adrenaline) Auto Injector Devices

Supply of Epinephrine (Adrenaline) Auto Injector Devices to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Urokinase Injections

Supply of Urokinase Injections to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Isosorbide Mononitrate Modified Release Capsules and Tablets

Supply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Diltiazem Hydrochloride Modified Release Capsules and Tablets

Supply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Verapamil Hydrochloride Modified Release Capsules and Tablets

Supply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Nifedipine Modified Release Capsules and Tablets

Supply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Theophylline Modified Release Capsules and Tablets

Supply of Theophylline Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Branded and Branded Generic Inhalers

Supply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Iloprost Medicines

Supply of Iloprost Solutions for Infusion and Nebuliser solutions to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Tinzaparin Sodium Injection

Supply of Tinzaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

All other Cardiovascular & Respiratory Medicines

Supply of all other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. Each product line was treated as an individual Lot. The Authority has awarded each product line to a single Framework Participant.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Tresprostinil Injection

Supply of Treprostinil Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Enoxaparin Sodium Injection

Supply of Enoxaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Dalteparin Injection

Supply of Dalteparin Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Icatibant Solution for Injection

Supply of Icatibant Solution for Injection to NHS Scotland. The Authority has awarded each product line as a multi-supplier ranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-03967f
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/021408-2023
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£56,782,632 £10M-£100M
Lots Value
£52,231,652 £10M-£100M
Awards Value
Not specified
Contracts Value
£53,346,651 £10M-£100M

Notice Dates

Publication Date
25 Jul 20233 years ago
Submission Deadline
10 Feb 2023Expired
Future Notice Date
Not specified
Award Date
3 Apr 20233 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Active, Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland

Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
46
Supplier Names

AOP Orphan Ltd

Accord-UK Ltd

Aguettant Ltd

Aspire Pharma Ltd

Aventis Pharma Ltd Trading As Sanofi

Baxter Healthcare Ltd

Beaumont Pharma Ltd

Bowmed Ibisqus Limited

CST Pharma Ltd

Chiesi Limited

Colonis Pharma Ltd

Consilient Health Ltd

Correvio GmbH

Crescent Pharma Limited

Day Lewis Medical Ltd

Dr Reddy's Laboratories (UK) Ltd

Ennogen Healthcare Ltd

Esteve Pharmaceuticals Ltd

Focus Pharmaceuticals Ltd

Galen Ltd

GlaxoSmithKline

Glenmark Pharmaceuticals Europe Ltd

Kent Pharmaceuticals Ltd

LEO Pharma

Lupin (Europe) Limited

Martindale Pharma

Mercury Pharma Group

Morningside Pharmaceuticals Limited

Neon Healthcare

P M Pharma Ltd

Pfizer Ltd

ROVI Biotech Limited

RPH Pharma Ltd

Ranbaxy UK Ltd

Rosemont Pharmaceuticals Ltd

Sandoz Ltd

Selective Supplies Ltd

Synchrony Pharma Ltd

Techdow Pharma England Ltd

Tetris Pharma Ltd

Teva UK Limited

Thornton & Ross

Viatris UK Healthcare Ltd

Wockhardt UK Limited

Zentiva Pharma UK Ltd

hameln pharma ltd

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...